2012 Aarkstore.com | Contraceptives – Pipeline Review, H2 2012 by aarks222


									Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Contraceptives – Pipeline Review, H2 2012

You can also request for sample page of above mention reports on


Global Markets Direct’s, Contraceptives - Pipeline Review, H2 2012, provides an
overview of the Contraceptives therapeutic pipeline. This report provides
information on the therapeutic development for Contraceptives, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Contraceptives.
Contraceptives - Pipeline Review, H2 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Contraceptives.
- A review of the Contraceptives products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

Table of contents:

List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Contraceptives Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Contraceptives 10
Contraceptives Therapeutics under Development by Companies 12
Late Stage Products 15
Comparative Analysis 15
Mid Clinical Stage Products 16
Comparative Analysis 16
Early Clinical Stage Products 17
Comparative Analysis 17
Pre-Clinical Stage Products 18
Comparative Analysis 18
Contraceptives Therapeutics – Products under Development by Companies 19
Companies Involved in Contraceptives Therapeutics Development 21
Antares Pharma, Inc. 21
Watson Pharmaceuticals, Inc. 22
Merck & Co., Inc. 23
BioSante Pharmaceuticals, Inc. 24
Teva Pharmaceutical Industries Limited 25
Bayer AG 26
Ligand Pharmaceuticals Incorporated 27
HRA Pharma, SA 28
Pantarhei Bioscience BV 29
Hydra Biosciences, Inc. 30
Agile Therapeutics, Inc. 31
Adamis Pharmaceuticals Corporation 32
Contraceptives – Therapeutics Assessment 34
Assessment by Monotherapy Products 34
Assessment by Route of Administration 35
Assessment by Molecule Type 37
Drug Profiles 39
MK-8175A - Drug Profile 39
Product Description 39
Mechanism of Action 39

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2

Astrocytoma – Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012

HIV / AIDS – Pipeline Review, H2 2012

Contraceptives – Pipeline Review, H2 2012

Metastatic Prostate Cancer – Pipeline Review, H2 2012

Fungal Infections – Pipeline Review, H2 2012

Mycobacterium Infections – Pipeline Review, H2 2012
Brain Cancer – Pipeline Review, H2 2012

Metastatic Colorectal Cancer – Pipeline Review, H2 2012

Orthomyxoviridae Infections – Pipeline Review, H2 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and

For More details Plz do contact :

Aarkstore Enterprise



Email: enquiry@aarkstore.com

To top